Abstract:The tumor specific internalization of therapeutics drug is been a great importance for cancer therapy. Targeted macromolecular carrier has been used as drug cargos since it improve the cellular uptake of cytotoxic drug in the tumor, while preventing cellular uptake by healthy tissues. Because of favorable pharmokinetic profile, elastin like polypeptide (ELPs) has been used as macromolecular drug carrier for cancer therapy. Fusion with cell-penetrating peptides (CPPs) such as TAT, assist easy penetration and internalization of macromolecular drug conjugates into wide variety of tumor types. For therapeutic peptide to be more penetrable and more effective towards specific tumor tissue, here we have designed a chimeric polypeptide cargo, TAT-AP1-ELP containing TAT, IL-4 receptor (IL4R) targeting peptide AP-1and thermal sensitive elastin-like polypeptides (ELPs). Then it was successfully expressed and purified from E coli using inverse temperature cycling method. Cellular uptake and intracellular localization of TAT-AP1-ELP was monitored through flow cytometry and confocal microscopy. Flow cytometry analysis data shown that both TAT-AP1-ELP and TAT-ELP showed various extends of penetration ability to different cancer cells but not to normal cells. Further a greater cellular uptake was observed in IL4R highly expressing cancer cells when treated with TAT-AP1-ELP compared to TAT-ELP at 37°C in dose-dependent manner. Confocal imaging verified the better cellular accumulation of TAT-AP1-ELP than TAT-ELP in IL4R highly expressing cancer cells. Importantly, the FNR 675-labeled TAT-AP1-ELP polymer showed better tumor accumulation in MDA-MB 231 xenograft mouse model. Thus in this study we demonstrate the improved activity of CPP, fused with targeting modalities in order to enhance intra tumor accumulation of therapeutic peptides. Citation Format: Young-Jin Lee, Vijaya Sarangthem, Yun-Jae Kim, Kuen Hur, Byung-Heon Lee, Rang Woon Park. Evaluation of tumor targeting activity by elastin like polypeptide containing cell penetrating peptide and IL-4 receptor targeting peptide. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 4391. doi:10.1158/1538-7445.AM2015-4391

Design and characterization of a novel tumor‐homing cell‐penetrating peptide for drug delivery in TGFBR3 high‐expressing tumors

Application of EGF-like Growth Factor-derived Tumor-homing Peptide for Antineoplastic Protein

De Novo Computational Design for Development of a Peptide Ligand Oriented to VEGFR-3 with High Affinity and Long Circulation.

Enhancing Tumor-Specific Intracellular Delivering Efficiency of Cell-Penetrating Peptide by Fusion with a Peptide Targeting to EGFR

Structure Optimisation to Improve the Delivery Efficiency and Cell Selectivity of a Tumour-Targeting Cell-Penetrating Peptide

Increased antitumor activity of tumor-specific peptide modified thymopentin.

TNYL Peptide Functional Chitosan-G-stearate Conjugate Micelles for Tumor Specific Targeting

Improved Tumor-Targeting Drug Delivery and Therapeutic Efficacy by Cationic Liposome Modified with Truncated Bfgf Peptide.

A Ph-Responsive Cell-Penetrating Peptide-Modified Liposomes with Active Recognizing of Integrin Αvβ3 for the Treatment of Melanoma.

Enhanced Anti-Tumor Activity of Trichosanthin after Combination with a Human-Derived Cell-Penetrating Peptide, and a Possible Mechanism of Activity

Structure-Based Design of Peptides against G3BP with Cytotoxicity on Tumor Cells.

A Novel Small Peptide As a Targeting Ligand for Receptor Tyrosine Kinase Tie2

Novel Peptide Targeting Integrin Αvβ3‐rich Tumor Cells by Magnetic Resonance Imaging

Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation

Characterization of a Novel Bispecific Antibody Targeting Tissue Factor-Positive Tumors with T Cell Engagement

Screening and Characterisation of a Novel Efficient Tumour Cell-Targeting Peptide Derived from Insulin-Like Growth Factor Binding Proteins

Improved Breast Cancer Cell-Specific Intracellular Drug Delivery and Therapeutic Efficacy by Coupling Decoration with Cell Penetrating Peptide and SP90 Peptide.

Constructing a Better Binding Peptide for Drug Delivery Targeting the Interleukin-4 Receptor

Developing New Peptides and Peptide-Drug Conjugates for Targeting the FGFR2 Receptor-Expressing Tumor Cells and 3D Spheroids

Extracellular Matrix-Trapped Bioinspired Lipoprotein Prolongs Tumor Retention to Potentiate Antitumor Immunity

Abstract 4391: Evaluation of tumor targeting activity by elastin like polypeptide containing cell penetrating peptide and IL-4 receptor targeting peptide